4-Aza Cyclopentenone Prostaglandin Analogues: Synthesis and NF-κB Inhibitory Activities

Area of Science:

• Medicinal Chemistry
• Organic Synthesis
• Molecular Biology

Background:

• Prostaglandins are a family of lipids with diverse physiological roles.
• Cyclopentenones are key structural motifs in natural prostaglandins.
• Nuclear Factor-kappa B (NF-κB) is a critical regulator of inflammation and immunity.

Purpose of the Study:

• To synthesize and characterize novel 4-aza, cross-conjugated cyclopentenone analogs.
• To evaluate the biological activity of these compounds in inhibiting NF-κB activation.
• To explore the structure-activity relationships of these analogs and their thiol adducts.

Main Methods:

• Synthesis of N-protected (4R)-aza-cyclopentenone using a modified Baylis-Hillman reaction.
• Introduction of various substituents to mimic prostaglandin ω-groups.
• Derivatization using tert-butyloxycarbonyl (Boc) protection for subsequent modifications.
• Biological evaluation of NF-κB inhibition and cytotoxicity assays.

Main Results:

• A series of 4-amino functionalized cross-conjugated cyclopentenones were successfully synthesized.
• These compounds demonstrated the ability to block NF-κB activation, comparable to natural prostanoids.
• Thiol adducts exhibited potent NF-κB inhibition, with some showing greater efficacy and lower cytotoxicity than precursors.
• Specific examples include cross-conjugated dieneone 12 (IC50 = 6.2 μM) and its cysteine adducts (IC50 = 1.0–8.0 μM).

Conclusions:

• Novel 4-aza, cross-conjugated cyclopentenones represent a promising class of NF-κB inhibitors.
• Thiol adducts offer potential for developing more effective and safer therapeutic agents.
• The synthetic strategies allow for diverse modifications to optimize biological activity.